In this episode of Better Thinking, Nesh Nikolic speaks with Paul Fitzgerald about the development of novel brain stimulation treatment options including repetitive transcranial magnetic stimulation (rTMS) for patients with depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer’s disease.
Paul Fitzgerald is the Head of the School of Medicine and Psychology at the Australian National University. He is a qualified psychiatrist, has a MBBS degree, Masters of Psychological Medicine and research PhD from Monash University.
He has conducted an extensive range of more than 20 clinical trials, especially focussed on the development of novel brain stimulation treatment options including repetitive transcranial magnetic stimulation (rTMS) for patients with depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer’s disease. He has had continual NHMRC grant support for over 20 years and over $10 million in research support in the last 5 years. He has published several books, over 500 journal articles and been cited over 20,000 times.
He has established multiple clinical rTMS services, founded several device and clinical service companies and the first rTMS training program in Australia. He led a national application to the Department of Health at the Federal Government level and this resulted in Medicare funding $283 million in year 1 of rTMS therapy for patients with depression in 2021.
Episode link at https://neshnikolic.com/podcast/paul-fitzgerald
